Ticker Details
Candel Therapeutics, Inc. Common Stock
IPO Date:	July 27, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$512.73M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.22 | 4.74%
Avg Daily Range (30 D):	$0.18 | 3.39%
Avg Daily Range (90 D):	$0.17 | 3.13%

Institutional Daily Volume
Avg Daily Volume:	.73M
Avg Daily Volume (30 D):	1.46M
Avg Daily Volume (90 D):	1.12M

Trade Size
Avg Trade Size (Sh.):	141
Avg Trade Size (Sh.) (30 D):	117
Avg Trade Size (Sh.) (90 D):	106

Institutional Trades
Total Institutional Trades:	124
Avg Institutional Trade:	$1.35M
Avg Institutional Trade (30 D):	$.72M
Avg Institutional Trade (90 D):	$.88M
Avg Institutional Trade Volume:	.19M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.74M
Avg Closing Trade (30 D):	$.73M
Avg Closing Trade (90 D):	$.98M
Avg Closing Volume:	264.71K

News

Feb 20, 2026 @ 1:56 PM Stock Market Today: Dow Jones, S&P 500 Futures Sl... Source: Rishabh Mishra

Feb 20, 2026 @ 2:40 AM Candel Therapeutics Announces Pricing of Public Of... Source: Na

Feb 19, 2026 @ 9:05 PM Candel Therapeutics Announces Proposed $100 Millio... Source: Globe Newswire

Jan 23, 2026 @ 10:52 AM Oncolytic Virotherapy Market - Global Industry Siz... Source: Researchandmarkets.Com

Nov 4, 2025 @ 2:00 PM Candel Therapeutics Showcases Immunotherapy Leader... Source: Candel Therapeutics

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.72	$-.55	$-.72
Diluted EPS	$-.72	$-.55	$-.72
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-38.18M	$-29.5M	$-38.18M
Operating Income / Loss	$-48.27M	$-15.75M	$-48.27M
Cost of Revenue
Net Cash Flow	$17.23M	$32.92M	$17.23M
PE Ratio